4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0001209191-20-032628
CEO acquired 6,172 shares (option exercise)
- CEO gave up 1,108 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
PIMSTONE SIMON N. · CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-05-26 | Exercise or conversion : show line 1 in the form | +6,172 | $3.56 | $21,972 | 264,294 | D |
| 2020-05-26 | Shares withheld for taxes : show line 2 in the form | −1,108 | $14.90 | $16,509 | 263,186 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-05-26 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −6,172 | 0 | D |
Loading xslF345X03/doc4.xml…